Trypanosoma brucei brucei causes Nagana in animals (Shi, Wei, Pan, & Tabel, 2006) . Leishmaniasis on the other hand is caused by over 20 different species of Leishmania and is transmitted by the sand fly.
Approximately 350 million people are at risk of infection in over 88 countries across the world (Bensoussan, Nasereddin, Jonas, Schnur, & Jaffe, 2006 ). An estimated 1.3 million new cases and 20,000 to 30,000 deaths occur annually (WHO, 2016a) . There are three forms of leishmaniasis: cutaneous, mucocutaneous, and visceral leishmaniasis (Alvar, Yactayo, & Bern, 2006; Desjeux, 2004; Herwaldt, 1999; Lysenko, 1971; Murray, Berman, Davies, & Saravia, 2005) . Last but not least, malaria, a typical protozoan infection that affects millions of people worldwide, is caused by Plasmodium species and transmitted by the female Anopheles mosquito. Sub-Saharan Africa alone accounts for 89% of malaria cases with 78% of malaria fatality occurring in children under 5 years old (WHO, 2015a) .
The control of all three protozoan infections is limited by drug toxicity, resistant strains of parasites, and economic/ financial factors. In the case of malaria for example, resistant malaria is a very serious problem worldwide. Quinine was the drug of choice for close to 100 years before it was replaced with artemisinin isolated from Artemisia annua due to the emergence of resistant parasites.
There are however reports of artemisinin failure in South East Asia making it necessary to develop new effective chemotherapy (Adeyemi et al., 2011; Bacchi, 2009; Balunas & Kinghorn, 2005; Singh & Sivakumar, 2004) . Despite the use of medicinal plants in the treatment of ailments including those caused by protozoan pathogens in Africa (Ankrah et al., 2003; Barrett, Boykin, Brun, & Tidwell, 2007; Okpekon et al., 2004; Rahmatullah et al., 2010; Trouiller et al., 2002) , scientific evidence of the medicinal properties of these plants have not been fully evaluated (Abu & Uchendu, 2011; Fathuddin, 2011; M. A. Ibrahim et al., 2010 ; N. Nweze, Anene, & Asuzu, 2011; Nweze, 2012; Ogbadoyi, Kabiru, & Omotosho, 2011; Wurochekke & Anyanwu, 2012) .
This study therefore aimed at screening selected Ghanaian medic- evaporator at 40°C to obtain the crude extract. The extracts were kept in sterile tubes and stored at 4°C until use. Prior to drug-sensitivity assays, 100-mg/ml stock solutions were prepared with 50% EtOH and filter sterilized.
| In vitro culture of parasitic protozoans
GUTat 3.1 strain of the bloodstream form of T. b. brucei was used for this study. Parasites were cultured in vitro according to conditions established previously (Yabu et al., 1998) . Parasites were used for assays when they reached a concentration of 1 × 10 6 parasites/ml.
Estimation of parasitemia was done with the Neubauer's counting chamber. Parasites were diluted to a concentration of 3 × 10 5 parasites/ml with HM1-9 medium and used for the various experiments.
For Leishmania parasites, promastigote forms of Leishmania donovani (MHOM/NP/03/D10) cultures were used in this study with the culture media previously established with slight modifications (Mottram, 2008) . The parasites were used for assays when they reached a concentration of 1 × 10 7 parasites/ml. Parasitemia was estimated with the Neubauer's counting chamber. Parasites were diluted to a concentration of 2.5 × 10 6 parasites/ml with M199 medium for drug assays.
For the maintenance of malaria cultures, 3D7 strain of Plasmodium falciparum was cultured based on previously established protocols with modifications (Trager & Jensen, 1976 for 24 and 4 hr in darkness, respectively. After 48 hr, the plate was read for absorbance at a wavelength of 540 nm (reference wavelength of 595 nm) using a spectrophotometer (TECAN Sunrise Wako, Japan).
Trend curves were drawn to obtain IC 50 values of plant extracts.
| Anti-Plasmodium activity
Fluorescent activated cell sorting (FACS) was used to determine the anti-Plasmodium activity of the plant extracts. Synchronized parasites at a packed volume of 2% hematocrit and 1% parasitemia were challenged with 0-to 25-μg/ml plant extracts for 48 hr. Artesunate (Sigma-Aldrich, USA) was used as the positive control, whereas RBCs at 2% hematocrit only and packed RBCs plus 2.5% EtOH served as negative and vehicle controls, respectively. SYBR Green I solution (0.25 μl of 10,000 × SYBR Green I/1 ml of 1 × phosphate buffered saline [PBS] ) was added to each well after the 48-hr incubation period and incubated for additional 30 min in the dark at 37°C. Plates were read using the Guava EasyCyte 5HT FACS machine (Millipore, USA) following the manufacturer's instructions.
| In vitro cytotoxicity assay
Jurkat cells (human acute T-cell leukemia cells) were obtained from the RIKEN BioResource Centre Cell Bank (Japan) and maintained in RPMI supplemented with 10% fetal bovine serum and 1% penicillinstreptomycin-L-glutamine. The cells were incubated at 37°C under 5% CO 2 in fully humidified conditions. The toxicity of plant extracts against the Jurkat cells was determined using a 3-(4,5-dimethyl- .
| Apoptosis assay
Nexin assay using EasyCyte 5HT FACS machine (Millipore, USA) was performed to investigate apoptotic properties of active crude extracts against T. brucei. Seeding and incubation of parasites with crude extracts were done under the same conditions of in vitro antiparasitic screening assay as described above. After 24 hr incubation, 10% Nexin reagent (Millipore, USA) was added to the Trypanosome culture and then subjected to FACS analysis (Guava EasyCyte 5HT, Millipore, USA) following the manufacture's instruction ).
2.6 | Effect of plant crude extract on Leishmania parasite morphology
To investigate the effect crude extracts with strong anti-Leishmania activity, IC 50 less than 20 μg/ml had on parasite morphology, fluorescence microscopy was performed with 4′,6-diamidino-2-phenylindole (DAPI).
Parasites were incubated with or without each anti-Leishmania active extract at a concentration twice the IC 50 value for 24 hr. Leishmania parasites were harvested and fixed with 70% EtOH on eight well chamber slides at −20°C for 1 hr. After washing twice with PBS for 5 min each and 0.1% Triton X-100 in PBS for 15 min at room temperature, parasite nucleus and kinetoplasts were stained with DAPI (5 μg/ml in PBS) for 10 min. Slides were then washed as described above, mounted with a mounting reagent and covered with cover slips. The slides were observed under the fluorescent microscope (Olympus, BX-530, Japan; Kwofie et al., 2016) .
3 | RESULTS
| In vitro antiparasitic activity
Plants and plant parts used in this study are indicated in values of the positive controls were 7.84, 0.1, and 0.01 μg/ml for berberine, amphotericin B, and artesunate, respectively.
The SI values for individual pathogens obtained using Jurkat cells are outlined in Table 2 . The SI values of all but one crude extracts with strong anti-Trypanosoma activity, IC 50 less than 20 μg/ml, were above 10.00. Acanthospermum hispidum whole plant extract was the only anti-Trypanosoma active extract with an SI value below 10, SI of 7.33.
With respect to anti-Leishmania active extracts, seven out of nine had SI values above 10.00. Parkia clappertoniana leaf extract and P. clappertoniana stem bark extract were the two extracts with SI values below 10, SI of 6.63 and 0.4, respectively. Three out of six anti-Plasmodium active extracts, Gossypium arboreum leaf and stem bark extracts, and Terminalia ivorensis leaf extract showed SI values greater than 10.00.
| Apoptosis inducing properties
The Nexin assay was performed to determine the apoptosis inducing properties of the eight anti-Trypanosoma active extracts. Parasites were challenged with 25 μg/ml of the active extracts for 24 hr and then subjected to apoptosis analysis. Morinda lucida induced the highest level of apoptosis (69.8%) against Trypanosoma parasites whereas the other extracts showed no significant induction of apoptotic cells (Figure 1) . No extract was observed to induce significant apoptosis-like cell death in Leishmania parasites and Plasmodium parasites using the Nexin assay and the mitochondrial membrane potential assays, respectively (data not shown). (Table 1) . We previously reported that the component(s) of a plant varied between plant parts. Coleus forskolii, for example, contains forskolin, an activator of cyclic AMP, only in some specific parts (Yanighara, Sakata, Shoyama, & Murakami, 1996) . We therefore collected different parts of each plant, leaf, fruit, seed, and/ or bark for our first-line screening. Another report showed that the concentration of plant components was partly dependent on the growth temperature (Shiping, Shan, Tanaka, & Shoyama, 1998) . Collection was therefore done in two separate locations to compare the effect of climate on the antiprotozoan activity of the selected plant species.
In this study, Ghanaian medicinal plants, with antiviral, antiparasitic, and antibacteria properties, were selected based on traditional knowledge. One hundred twelve ethanolic extracts representing 72 plant species belonging to 38 families were screened for their antiprotozoan activities against Trypanosoma, Leishmania, and Plasmodium parasites.
Although many of them have previously been reported to be effective against protozoan, diarrheal, bacterial, and other infectious diseases (Adepiti, Adewunmi, & Agbedahunsi, 2014; Bizimana et al., 2006; Chakraborty, Gaikwad, & Singh, 2012; Deepa & Rajendran, 2007; Lim, 2012; Mesia et al., 2007; Mothana et al., 2010; Mukhtar et al., 2008; Musuyu Muganza et al., 2012; Namukobe et al., 2011; Phillipson, 2001; Ravikumar, Inbaneson, Suganthi, Gokulakrishnan, & Venkatesan, 2011; Ríos & Recio, 2005; Sundararajan et al., 2006; Tajudeen & Kuranga, 2013; Yadav & Agarwala, 2011) , we report the antiprotozoan activity of many crude extracts for the first time.
We confirmed high anti-Trypanosoma activity in 11 crude extracts, (Abedo et al., 2013; Bero, Hannaert, Chataigné, Hérent, & Quenti-Leclercq, 2011; Ganfon et al., 2012; Kimani, Gathumbi, Auma, Ngeranwa, & Masiga, 2013; Mann et al., 2011; Shuaibu et al., 2008) . The possible mechanisms of action are however unknown.
M. lucida was the only extract observed to induce significant apoptosis-like cell death in Trypanosoma parasites through the externalization of phosphotidyl serine. Subsequent bioassay-guided fractionation of M. lucida leaf extracts led to the identification of three novel tetracyclic iridoid compounds, two of which induced significant apoptosis-like cell death in Trypanosoma parasites in vitro (Karasawa et al., 2016; Kwofie et al., 2016; Suzuki et al., 2015) . Thus, these compounds may be responsible for the apoptosis inducing properties of the M. lucida leaf extract in Trypanosoma parasites. Although M. lucida leaf extracts showed neither anti-Leishmania nor anti-Plasmodium activity, two of the three compounds had anti-Leishmania activity whereas all three had anti-Plasmodium activity.
In the anti-Leishmania activity screening, the promastigote form of the parasite was used. This is because Leishmania promastigotes are easier to handle making them more convenient for first-line screening of a large number of extracts or compounds. Moreover, extracts with This study reports the anti-Leishmania activity of six of the eight active plant species for the first time with A. senegalensis and Z. zanthoxyloides, the only ones previously reported to possess anti-Leishmania activity (Sahpaz et al., 1994) . With respect to extract activity against multiple parasites, C. cordifolia and Z. zanthoxyloides were found to have activity against both Trypanosoma and Leishmania parasites. The Z. zanthoxyloides stem bark extract however had only anti-Trypanosoma activity whereas its root extract had only anti-Leishmania activity.
This difference may be attributed to the differences in chemical components and/or concentration in different plant parts. Both T. ivorensis stem bark and leaf extracts were active against Trypanosoma and Plasmodium parasites.
In addition to the anti-Leishmania activity, we found A. senegalensis With respect to the anti-Plasmodium activity, six extracts from five plant species were observed to have high anti-Plasmodium activity: Alchornea cordifolia (leaves), Anogeissus schimperi (leaves), Gossypium arboretum (leaves), Mangifera indica (leaves), and T. ivorensis (stem bark and leaves). Although all five plant species had previously been reported to have anti-Plasmodium activity, the plant parts, extracts, differed in activity from previous reports. The leaves, flowers, and bark of M. indica, for example, had previously been reported to have anti-Plasmodium activity (Bidla et al., 2004; H. A. Ibrahim et al., 2012) . Our study however found only the leaf extracts to have antiPlasmodium activity (Table 2 ). This may be due to the effect of seasons and/or habitats on the constituents of plants. Regarding the components of mango, although it has been suggested that the most important constituent in mango-related antiparasitic activity is mangiferin having the C-glucosyl xanthone structure (Wauthoz & Balde, 2007) , the active component is still unknown. In this regard, we intend to employ the bioassay-guided fractionation techniques to determine the active components of the promising anti-Plasmodium active extracts as in the case of M. lucida .
Moving forward, our aim is not only to determine the active components but also to test the prospects of using active extracts to develop herbal based treatment drugs at the Center for Plant Medicine Research, Ghana. Work is currently ongoing to replicate the efficacy of selected active extracts and compounds in vivo. Also, although climate had no significant effect on the activity of active extracts, there is the need to determine the seasonal activity of each/selected active extracts. This study however shows the prospects of Ghanaian medicinal plants in the development of new chemotherapy against protozoan infections.
| CONCLUSION
In conclusion, all 23 extracts with high antiparasitic activity showed high selectivity for at least one of the three parasites.
Anti-Trypanosoma active compounds induced apoptosis in
Trypanosoma parasites whereas anti-Leishmania active extracts caused morphological changes in the Leishmania parasite.
Overall, the results obtained from the crude extracts screening, especially all extracts with anti-Trypanosoma, anti-Leishmania, and anti-Plasmodium activities, suggest that these may be promising sources for the development of new drugs for controlling African trypanosomiasis, leishmaniasis, and malaria.
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